Alzheimer’s Drug Lecanemab Shows Promising Results In Slowing Disease – SlashGear

People do not go to sleep cognitively healthy and wake up the next morning with Alzheimer’s Disease. The affliction falls more of a continuum, as the Alzheimer’s Organization explains. There are five distinctive stages: preclinical, mild cognitive impairment, mild dementia, moderate dementia, and severe dementia. In the first stage, the disease’s victim doesn’t look like an Alzheimer’s patient; they may still be young, only in their 50s or 60s, go to work, carry on normal conversations and relationships, and remember details about their own and their loved ones’ identities. The changes right now are purely biological ones, culminating stealthily in the brain, but by the third stage, impact on everyday activity is starting, and by the last — brain damage is so severe that the patients, usually nonverbal or close to it, are bed-bound and require ’round-the-clock care.

One American develops Alzheimer’s Disease every minute, says the BrightFocus Alzheimer’s Disease Research Foundation, and studies have identified several risk factors for Alzheimer’s. Currently, there is only one authority-approved drug approved for Alzheimer’s treatment, according to the National Institute on Aging.